COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF
Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for prepa...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LI, SONG YAN, JIE ZHI, JIANQIONG XU, WENJIE ZHENG, YANXIN |
| description | Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
L'invention concerne un composite supramoléculaire comprenant un composé bloquant le récepteur de l'angiotensine II (AT1), un inhibiteur de l'endopeptidase neutre (NEPi) et un cation pharmaceutiquement acceptable. L'invention concerne également un procédé permettant de préparer le composite et une application du composite pour préparer un produit pharmaceutique destiné au traitement de l'insuffisance cardiaque. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3016258A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3016258A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3016258A13</originalsourceid><addsrcrecordid>eNqNzE0KwjAQhuFuXIh6hzmAgrUobtN02gzYmZCO61Ikrvwp1PtjFA_g6oOHl2-e3a20Xs5cdSA1GG5IFLkjBiIIaNGrhORqGmHqFFpUU8qJFJNWwOiB2FFJqVt_yQf0Jhgl4U_tJH2rw4BSL7PZdbhNcfXbRQY1qnWbOD77OI3DJT7iq7em2OaH3f5o8uKP5A3V2jaP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF</title><source>esp@cenet</source><creator>LI, SONG ; YAN, JIE ; ZHI, JIANQIONG ; XU, WENJIE ; ZHENG, YANXIN</creator><creatorcontrib>LI, SONG ; YAN, JIE ; ZHI, JIANQIONG ; XU, WENJIE ; ZHENG, YANXIN</creatorcontrib><description>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
L'invention concerne un composite supramoléculaire comprenant un composé bloquant le récepteur de l'angiotensine II (AT1), un inhibiteur de l'endopeptidase neutre (NEPi) et un cation pharmaceutiquement acceptable. L'invention concerne également un procédé permettant de préparer le composite et une application du composite pour préparer un produit pharmaceutique destiné au traitement de l'insuffisance cardiaque.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170727&DB=EPODOC&CC=CA&NR=3016258A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170727&DB=EPODOC&CC=CA&NR=3016258A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI, SONG</creatorcontrib><creatorcontrib>YAN, JIE</creatorcontrib><creatorcontrib>ZHI, JIANQIONG</creatorcontrib><creatorcontrib>XU, WENJIE</creatorcontrib><creatorcontrib>ZHENG, YANXIN</creatorcontrib><title>COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF</title><description>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
L'invention concerne un composite supramoléculaire comprenant un composé bloquant le récepteur de l'angiotensine II (AT1), un inhibiteur de l'endopeptidase neutre (NEPi) et un cation pharmaceutiquement acceptable. L'invention concerne également un procédé permettant de préparer le composite et une application du composite pour préparer un produit pharmaceutique destiné au traitement de l'insuffisance cardiaque.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzE0KwjAQhuFuXIh6hzmAgrUobtN02gzYmZCO61Ikrvwp1PtjFA_g6oOHl2-e3a20Xs5cdSA1GG5IFLkjBiIIaNGrhORqGmHqFFpUU8qJFJNWwOiB2FFJqVt_yQf0Jhgl4U_tJH2rw4BSL7PZdbhNcfXbRQY1qnWbOD77OI3DJT7iq7em2OaH3f5o8uKP5A3V2jaP</recordid><startdate>20170727</startdate><enddate>20170727</enddate><creator>LI, SONG</creator><creator>YAN, JIE</creator><creator>ZHI, JIANQIONG</creator><creator>XU, WENJIE</creator><creator>ZHENG, YANXIN</creator><scope>EVB</scope></search><sort><creationdate>20170727</creationdate><title>COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF</title><author>LI, SONG ; YAN, JIE ; ZHI, JIANQIONG ; XU, WENJIE ; ZHENG, YANXIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3016258A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI, SONG</creatorcontrib><creatorcontrib>YAN, JIE</creatorcontrib><creatorcontrib>ZHI, JIANQIONG</creatorcontrib><creatorcontrib>XU, WENJIE</creatorcontrib><creatorcontrib>ZHENG, YANXIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI, SONG</au><au>YAN, JIE</au><au>ZHI, JIANQIONG</au><au>XU, WENJIE</au><au>ZHENG, YANXIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF</title><date>2017-07-27</date><risdate>2017</risdate><abstract>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
L'invention concerne un composite supramoléculaire comprenant un composé bloquant le récepteur de l'angiotensine II (AT1), un inhibiteur de l'endopeptidase neutre (NEPi) et un cation pharmaceutiquement acceptable. L'invention concerne également un procédé permettant de préparer le composite et une application du composite pour préparer un produit pharmaceutique destiné au traitement de l'insuffisance cardiaque.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3016258A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOUNDS OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR, AND PREPARATION METHODS THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A24%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI,%20SONG&rft.date=2017-07-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3016258A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |